The patient-reported form of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) assesses perceived problems attributable to cognitive and neuropsychiatric symptoms. It is inconsistently related to objective cognitive performance in multiple sclerosis (MS), while strongly correlated with depression. We assessed whether the relationship between subjective and objective cognitive screening tools is moderated by disability. Furthermore, we investigated the MSNQ as a screening tool for both cognitive impairment and depression. 275 MS patients completed the patient-reported MSNQ, two-question screening tool for depression and Symbol Digit Modalities Test (SDMT) and were divided into Expanded Disability Status Scale (EDSS) subgroups: Low 0.0-3.0, Medium 3.5-6.0, High 6.5-9.0. MSNQ scores correlated significantly with depression but not SDMT in all subgroups. After correcting for age, sex, education, EDSS and depression, MSNQ significantly predicted SDMT in the total group, but not the subgroups. MSNQ significantly predicted a positive depression and/or cognitive impairment screen in the total group and all subgroups. The relationship between subjective and objective cognitive screening tools is not influenced by physical disability. MSNQ scores are substantially influenced by depression, and reflect cognitive function to some degree. Patient-reported cognitive measures can be useful to identify patients requiring further (neuro)psychological assessment.
Van Laethem, D , De Cock, A , Van Schependom, J , Benedict, RHB , Nagels, G & D'hooghe, M 2022, ' Correlates of patient-reported cognitive performance with regard to disability ', Scientific Reports , vol. 12, no. 1, 13489.
Van Laethem, D. , De Cock, A. , Van Schependom, J. , Benedict, R. H. B. , Nagels, G. , & D'hooghe, M. (2022). Correlates of patient-reported cognitive performance with regard to disability . Scientific Reports , 12 (1), [13489].
@article{bab00a2adeb24231a53a6fba92b4f2bf,
title = " Correlates of patient-reported cognitive performance with regard to disability " ,
abstract = " The patient-reported form of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) assesses perceived problems attributable to cognitive and neuropsychiatric symptoms. It is inconsistently related to objective cognitive performance in multiple sclerosis (MS), while strongly correlated with depression. We assessed whether the relationship between subjective and objective cognitive screening tools is moderated by disability. Furthermore, we investigated the MSNQ as a screening tool for both cognitive impairment and depression. 275 MS patients completed the patient-reported MSNQ, two-question screening tool for depression and Symbol Digit Modalities Test (SDMT) and were divided into Expanded Disability Status Scale (EDSS) subgroups: Low 0.0-3.0, Medium 3.5-6.0, High 6.5-9.0. MSNQ scores correlated significantly with depression but not SDMT in all subgroups. After correcting for age, sex, education, EDSS and depression, MSNQ significantly predicted SDMT in the total group, but not the subgroups. MSNQ significantly predicted a positive depression and/or cognitive impairment screen in the total group and all subgroups. The relationship between subjective and objective cognitive screening tools is not influenced by physical disability. MSNQ scores are substantially influenced by depression, and reflect cognitive function to some degree. Patient-reported cognitive measures can be useful to identify patients requiring further (neuro)psychological assessment. " ,
keywords = " Multiple Sclerosis Neuropsychological Questionnaire (, cognitive symptoms, neuropsychiatric symptoms, multiple sclerosis, depression " ,
author = " {Van Laethem}, Delphine and {De Cock}, Alexander and {Van Schependom}, Jeroen and Benedict, {Ralph H B} and Guy Nagels and Marie D'hooghe " ,
note = " { extcopyright} 2022. The Author(s). " ,
year = " 2022 " ,
month = aug,
day = " 5 " ,
doi = " 10.1038/s41598-022-17649-3 " ,
language = " English " ,
volume = " 12 " ,
journal = " Scientific Reports " ,
issn = " 2045-2322 " ,
publisher = " Nature Publishing Group " ,
number = " 1 " ,
}